Fairfield, Bush & Co. Tilray Brands, Inc. Transaction History

Fairfield, Bush & Co.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 13, 2024	BUY	$1.66 - $2.41 $7,244 - $10,517	4,364 New	4,364 $10 Million
Q2 2023 Aug 15, 2023	BUY	$1.52 - $2.78 $13,518 - $24,725	8,894 New	8,894 $13.9 Million
Q2 2022 Aug 09, 2022	SELL	$3.11 - $7.48 $3,110 - $7,480	-1,000 Reduced 7.24%	12,803 $40,000
Q1 2022 May 06, 2022	SELL	$4.88 - $8.56 $24,400 - $42,800	-5,000 Reduced 26.59%	13,803 $107,000
Q4 2021 Feb 09, 2022	SELL	$7.03 - $13.03 $36,556 - $67,756	-5,200 Reduced 21.66%	18,803 $132,000
Q3 2021 Nov 08, 2021	SELL	$11.11 - $17.84 $5,799 - $9,312	-522 Reduced 2.13%	24,003 $271,000
Q2 2021 Aug 02, 2021	BUY	$13.68 - $22.34 $104,788 - $171,124	7,660 Added 45.42%	24,525 $443,000
Q1 2021 May 14, 2021	BUY	$9.0 - $63.91 $151,785 - $1.08 Million	16,865 New	16,865 $383,000

405

99.8M

8.6M

8.9M

Ticker TLRY
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 611,401,984
Market Cap $874M
Description
Tilray Brands, Inc. engages in the research, cultivation, production, marketing, and distribution of medical cannabis products in Canada, the United States, Europe, Australia, New Zealand, Latin America, and internationally. The company operates through four segments: Cannabis Business, Distribution Business, Beverage Alcohol Business, and Welln...

Get notified when there are updates to the investment portfolio of Fairfield, Bush & Co., based on Form 13F filings with the SEC.

Stay updated on Fairfield, Bush & Co. with notifications on news.